RTW Biotech Opportunities (LON:RTW – Get Free Report) traded up 1.5% during mid-day trading on Thursday . The stock traded as high as GBX 1.37 ($0.02) and last traded at GBX 1.37 ($0.02). 28,823 shares changed hands during trading, a decline of 96% from the average session volume of 738,808 shares. The stock had previously closed at GBX 1.35 ($0.02).
RTW Biotech Opportunities Trading Up 1.5 %
The stock’s fifty day simple moving average is GBX 1.32 and its 200 day simple moving average is GBX 1.29. The company has a market cap of £5.27 million, a price-to-earnings ratio of 3.81 and a beta of 0.60.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Featured Articles
- Five stocks we like better than RTW Biotech Opportunities
- 3 Monster Growth Stocks to Buy Now
- Roblox: The Bottom Just Fell Out of the Metaverse
- What is an Earnings Surprise?
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- Do ETFs Pay Dividends? What You Need to Know
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
